What Two Sigma Advisers LP changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$0
$7.0bn at Q2 2013
Positions
0
2,136 at Q2 2013
Top ten weight
n.a.
19% at Q2 2013
Typical quarterly turnover
about 26%
Estimated from share changes
- Q2 2013: $7.0bn
- Q3 2013: $8.4bn
- Q4 2013: $10.4bn
- Q1 2014: $11.0bn
- Q2 2014: $12.8bn
- Q3 2014: $13.3bn
- Q4 2014: $12.9bn
- Q1 2015: $13.6bn
- Q2 2015: $13.4bn
- Q3 2015: $15.9bn
- Q4 2015: $16.8bn
- Q1 2016: $17.9bn
- Q2 2016: $19.7bn
- Q3 2016: $23.5bn
- Q4 2016: $26.1bn
- Q1 2017: $30.5bn
- Q2 2017: $30.3bn
- Q3 2017: $35.3bn
- Q4 2017: $37.1bn
- Q1 2018: $36.9bn
- Q2 2018: $37.2bn
- Q3 2018: $41.0bn
- Q4 2018: $36.6bn
- Q1 2019: $39.7bn
- Q2 2019: $40.2bn
- Q3 2019: $40.9bn
- Q4 2019: $43.1bn
- Q1 2020: $26.1bn
- Q2 2020: $34.0bn
- Q3 2020: $35.0bn
- Q4 2020: $37.4bn
- Q1 2021: $36.4bn
- Q2 2021: $37.9bn
- Q3 2021: $38.6bn
- Q4 2021: $39.9bn
- Q1 2022: $37.6bn
- Q2 2022: $35.3bn
- Q3 2022: $34.5bn
- Q4 2022: $35.8bn
- Q1 2023: $38.8bn
- Q2 2023: $39.3bn
- Q3 2023: $39.0bn
- Q4 2023: $42.7bn
- Q1 2024: $43.2bn
- Q2 2024: $44.8bn
- Q3 2024: $42.7bn
- Q4 2024: $43.2bn
- Q1 2025: $44.4bn
- Q2 2025: $48.8bn
- Q3 2025: $50.0bn
- Q4 2025: $51.4bn
- Q1 2026: $0
- Q2 2026: $0
- Q2 2013: 19%
- Q3 2013: 14%
- Q4 2013: 14%
- Q1 2014: 13%
- Q2 2014: 13%
- Q3 2014: 10%
- Q4 2014: 10%
- Q1 2015: 9%
- Q2 2015: 9%
- Q3 2015: 9%
- Q4 2015: 10%
- Q1 2016: 11%
- Q2 2016: 12%
- Q3 2016: 10%
- Q4 2016: 9%
- Q1 2017: 9%
- Q2 2017: 10%
- Q3 2017: 10%
- Q4 2017: 9%
- Q1 2018: 8%
- Q2 2018: 9%
- Q3 2018: 10%
- Q4 2018: 10%
- Q1 2019: 10%
- Q2 2019: 11%
- Q3 2019: 12%
- Q4 2019: 12%
- Q1 2020: 12%
- Q2 2020: 14%
- Q3 2020: 13%
- Q4 2020: 12%
- Q1 2021: 14%
- Q2 2021: 13%
- Q3 2021: 13%
- Q4 2021: 13%
- Q1 2022: 14%
- Q2 2022: 13%
- Q3 2022: 14%
- Q4 2022: 14%
- Q1 2023: 12%
- Q2 2023: 14%
- Q3 2023: 16%
- Q4 2023: 17%
- Q1 2024: 17%
- Q2 2024: 18%
- Q3 2024: 17%
- Q4 2024: 20%
- Q1 2025: 18%
- Q2 2025: 19%
- Q3 2025: 19%
- Q4 2025: 19%
- Q1 2026: 0%
- Q2 2026: 0%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q3 2016 | $1.7bnQ4 2025 | Soldlast listed Q4 2025 | |
| Apple Inc(AAPL) | Q3 2013 | $1.6bnQ4 2025 | Soldlast listed Q4 2025 | |
| Microsoft Corp(MSFT) | Q3 2014 | $1.5bnQ3 2025 | Soldlast listed Q4 2025 | |
| Amazon Com Inc(AMZN) | Q1 2015 | $1.1bnQ4 2025 | Soldlast listed Q4 2025 | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q4 2015 | $801mQ2 2025 | Soldlast listed Q4 2025 | |
| JPMorgan Chase & Co(JPM) | Q2 2013 | $769mQ3 2025 | Soldlast listed Q4 2025 | |
| Facebook Inc A(META)Class A | Q3 2014 | $726mQ4 2024 | Soldlast listed Q4 2025 | |
| Mastercard Inc(MA)Class A | Q3 2014 | $701mQ4 2025 | Soldlast listed Q4 2025 |
Quarter by quarter
Q3 2016: $23.5bn across 2,191 positions
Against Q2 2016: 433 new, 918 added to, 825 trimmed, 271 sold out, across all 2,191 positions.
Turnover about 25% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Celgene Corp+$178m
- Salesforce Com Inc (CRM)+$136m
- Verizon Communications Inc (VZ)+$134m
- Target Corp (TGT)+$120m
- United Parcel Service Inc (UPS)+$110m
- Philip Morris Intl Inc (PM)+$101m
- Mastercard Inc (MA)+$95m
- CVS Caremark Corporation (CVS)+$92m
Largest reductions
- Spdr S&P 500 Etf Trust (SPY)-$169m
- Facebook Inc A (META)-$121m
- Powershares QQQ Trust-$110m
- Yum Brands Inc (YUM)-$107m
- Electronic Arts Inc (EA)-$90m
- Teva Pharmaceutical Inds LTD (TEVA)-$77m
- Qualcomm Inc (QCOM)-$74m
- Smucker J M Co (SJM)-$72m
Opened
- Wal-mart Stores Inc (WMT)$237m
- TJX Cos Inc New (TJX)$203m
- Select Sector SPDR Shares Of Beneficial Interest Cons Staples (XLP)$176m
Sold out
- Johnson Controls Incwas $102m
- E M C Corp Masswas $102m
- Biogen Idec Inc (BIIB)was $96m
- Allergan PLCwas $91m
- Starwood Hotels&resorts WRLDwas $90m
- iShares Trust (IBB)was $42m
- Tyco Intl PLCwas $41m
- Sempra Energy (SRE)was $38m
Largest positions, Q3 2016
The largest 25 of 2,191 reported positions; the largest 500 carry 87.3% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Amazon Com Inc (AMZN) | $299m | 1.3% | Added |
| Alphabet Inc (GOOGL) | $294m | 1.3% | Added |
| Home Depot Inc (HD) | $245m | 1.0% | Added |
| Dow Chem Co | $239m | 1.0% | Added |
| Wal-mart Stores Inc (WMT) | $237m | 1.0% | New |
| Wells Fargo & Co New (WFC) | $228m | 1.0% | Added |
| McDonald's Corp (MCD) | $228m | 1.0% | Added |
| Spdr S&P 500 Etf Trust (SPY) | $227m | 1.0% | Trimmed |
| Gilead Sciences Inc (GILD) | $223m | 1.0% | Added |
| Philip Morris Intl Inc (PM) | $203m | 0.9% | Added |
| TJX Cos Inc New (TJX) | $203m | 0.9% | New |
| Marriott Intl Inc New (MAR) | $196m | 0.8% | Added |
| Du Pont E I de Nemours & Co | $193m | 0.8% | Trimmed |
| NIKE Inc (NKE) | $191m | 0.8% | Added |
| Lam Research Corp | $189m | 0.8% | Added |
| Celgene Corp | $186m | 0.8% | Added |
| Lowes Cos Inc (LOW) | $178m | 0.8% | Added |
| Kimberly Clark Corp (KMB) | $177m | 0.8% | Added |
| Expedia Inc Del (EXPE) | $177m | 0.8% | Added |
| Select Sector SPDR Shares Of Beneficial Interest Cons Staples (XLP) | $176m | 0.7% | New |
| Applied Matls Inc (AMAT) | $173m | 0.7% | Trimmed |
| Abbvie Inc (ABBV) | $163m | 0.7% | Added |
| Verizon Communications Inc (VZ) | $162m | 0.7% | Added |
| Salesforce Com Inc (CRM) | $161m | 0.7% | Added |
| Yahoo Inc | $157m | 0.7% | Added |
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Two Sigma Advisers LP | $0 | 13F-HR | |
| Q1 2026 | Two Sigma Advisers LP | $0 | 13F-HR | |
| Q4 2025 | Two Sigma Advisers LP | $51.4bn | 13F-HR | |
| Q3 2025 | Two Sigma Advisers LP | $50.0bn | 13F-HR | |
| Q2 2025 | Two Sigma Advisers LP | $48.8bn | 13F-HR | |
| Q1 2025 | Two Sigma Advisers LP | $44.4bn | 13F-HR | |
| Q4 2024 | Two Sigma Advisers LP | $43.2bn | 13F-HR | |
| Q3 2024 | Two Sigma Advisers LP | $42.7bn | 13F-HR | |
| Q2 2024 | Two Sigma Advisers LP | $44.8bn | 13F-HR | |
| Q1 2024 | Two Sigma Advisers LP | $43.2bn | 13F-HR | |
| Q4 2023 | Two Sigma Advisers LP | $42.7bn | 13F-HR | |
| Q3 2023 | Two Sigma Advisers LP | $39.0bn | 13F-HR | |
| Q2 2023 | Two Sigma Advisers LP | $39.3bn | 13F-HR | |
| Q1 2023 | Two Sigma Advisers LP | $38.8bn | 13F-HR | |
| Q4 2022 | Two Sigma Advisers LP | $35.8bn | 13F-HR | |
| Q3 2022 | Two Sigma Advisers LP | $34.5bn | 13F-HR | |
| Q2 2022 | Two Sigma Advisers LP | $35.3bn | 13F-HR | |
| Q1 2022 | Two Sigma Advisers LP | $37.6bn | 13F-HR | |
| Q4 2021 | Two Sigma Advisers LP | $39.9bn | 13F-HR | |
| Q3 2021 | Two Sigma Advisers LP | $38.6bn | 13F-HR | |
| Q2 2021 | Two Sigma Advisers LP | $37.9bn | 13F-HR | |
| Q1 2021 | Two Sigma Advisers LP | $36.4bn | 13F-HR | |
| Q4 2020 | Two Sigma Advisers LP | $37.4bn | 13F-HR | |
| Q3 2020 | Two Sigma Advisers LP | $35.0bn | 13F-HR | |
| Q2 2020 | Two Sigma Advisers LP | $34.0bn | 13F-HR | |
| Q1 2020 | Two Sigma Advisers LP | $26.1bn | 13F-HR | |
| Q4 2019 | Two Sigma Advisers LP | $43.1bn | 13F-HR | |
| Q3 2019 | Two Sigma Advisers LP | $40.9bn | 13F-HR | |
| Q2 2019 | Two Sigma Advisers LP | $40.2bn | 13F-HR | |
| Q1 2019 | Two Sigma Advisers LP | $39.7bn | 13F-HR | |
| Q4 2018 | Two Sigma Advisers LP | $36.6bn | 13F-HR | |
| Q3 2018 | Two Sigma Advisers LP | $41.0bn | 13F-HR | |
| Q2 2018 | Two Sigma Advisers LP | $37.2bn | 13F-HR | |
| Q1 2018 | Two Sigma Advisers LP | $36.9bn | 13F-HR | |
| Q4 2017 | Two Sigma Advisers LP | $37.1bn | 13F-HR | |
| Q3 2017 | Two Sigma Advisers LP | $35.3bn | 13F-HR | |
| Q2 2017 | Two Sigma Advisers LP | $30.3bn | 13F-HR | |
| Q1 2017 | Two Sigma Advisers LP | $30.5bn | 13F-HR | |
| Q4 2016 | Two Sigma Advisers LP | $26.1bn | 13F-HR | |
| Q3 2016 | Two Sigma Advisers LP | $23.5bn | 13F-HR | |
| Q2 2016 | Two Sigma Advisers LP | $19.7bn | 13F-HR | |
| Q1 2016 | Two Sigma Advisers LP | $17.9bn | 13F-HR | |
| Q4 2015 | Two Sigma Advisers LP | $16.8bn | 13F-HR | |
| Q3 2015 | Two Sigma Advisers LP | $15.9bn | 13F-HR | |
| Q2 2015 | Two Sigma Advisers LP | $13.4bn | 1 | 13F-HR |
| Q1 2015 | Two Sigma Advisers LP | $13.6bn | 1 | 13F-HR |
| Q4 2014 | Two Sigma Advisers LP | $12.9bn | 1 | 13F-HR |
| Q3 2014 | Two Sigma Advisers LP | $13.3bn | 1 | 13F-HR |
| Q2 2014 | Two Sigma Advisers LP | $12.8bn | 1 | 13F-HR |
| Q1 2014 | Two Sigma Advisers LP | $11.0bn | 13F-HR | |
| Q4 2013 | Two Sigma Advisers LP | $10.4bn | 13F-HR | |
| Q3 2013 | Two Sigma Advisers LP | $8.4bn | 13F-HR | |
| Q2 2013 | Two Sigma Advisers LP | $7.0bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More